Immucell (ICCC) Inventory (2010 - 2026)

Immucell (ICCC) has reported Inventory for 17 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 9.45% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2026 stood at $9.1 million (up 9.45% YoY), and the FY2025 full-year result was $9.3 million, up 30.29% from the prior year.
• Inventory slipped to $9.1 million in Q2 2026 per ICCC's latest filing, from $9.3 million in the prior quarter.
• Across five years, Inventory topped out at $9.8 million in Q3 2025 and bottomed at $3.4 million in Q1 2022.
• Historically, Inventory has averaged $7.1 million across 5 years, with a median of $7.4 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Inventory soared 99.39% in 2022, then declined 8.95% in 2024.
• Over 5 years, Inventory stood at $6.0 million in 2022, then grew by 29.37% to $7.8 million in 2023, then slipped by 8.95% to $7.1 million in 2024, then surged by 30.29% to $9.3 million in 2025, then fell by 2.04% to $9.1 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $9.1 million, $9.3 million, and $9.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.